There are 2934 resources available
Targeted KRAS mutation
Presenter: Pasi Jänne
Session: The next horizon in metastatic non-small cell targeted therapy
Resources:
Slides
Webcast
Uncommon targets: BRAF, MET and NTRK
Presenter: David Planchard
Session: The next horizon in metastatic non-small cell targeted therapy
Resources:
Slides
Webcast
IDEA collaboration for HR stage II
Presenter: Alberto Sobrero
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
TOSCA trial
Presenter: Sara Lonardi
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
Introduction
Presenter: Alberto Sobrero
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
How do you treat high-risk stage II colon cancer patients? Nothing vs. FP vs. doublet including MSI high patients
Presenter: Claus-Henning Koehne
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
SCOT trial
Presenter: Timothy Iveson
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
HORG trial
Presenter: Ioannis Souglakos
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
Panel discussion
Presenter: Claus-Henning Koehne
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
New IDEA collaboration ‘CIRCULATE IDEA’
Presenter: Takayuki Yoshino
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast